SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, ...

A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentation has concluded. About BioAtla®, Inc.

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced its selection to present a poster at the European Society of Medical ...

PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI (Extended-Release Fluticasone ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Department of Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center This poster will feature the TRIDENT study, which leverages machine learning to develop multimodal signatures ...

As diagnoses of autism spectrum disorder have increased in the last two decades, so have the number of experimental and ...

First whale sighting contest begins Whatʻs your best guess? Whale season will be here in Hawaiʻi before you know it. When do ...